Bioorthogonal “Click and Release” Reaction‐Triggered Aggregation of Gold Nanoparticles Combined with Released Lonidamine for Enhanced Cancer Photothermal Therapy
Angewandte Chemie International Edition · 2024
DOI: 10.1002/anie.202318539 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2024. Verfasst von Xiao Yan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China. Hauptthemen laut MEDLINE: Metal Nanoparticles, Nanoparticles, Neoplasms, Prodrugs. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cancer has been the most deadly disease, and 13 million cancer casualties are estimated to occur each year by 2030. Gold nanoparticles (AuNPs)‐based photothermal therapy (PTT) has attracted great interest due to its high spatiotemporal controllability and noninvasiveness. Due to the trade‐off between particle size and photothermal efficiency of AuNPs, rational design is needed to realize aggregation of AuNPs into larger particles with desirable NIR adsorption in tumor site. Exploiting the bioorthogonal “Click and Release” (BCR) reaction between iminosydnone and cycloalkyne, aggregation of AuNPs can be achieved and attractively accompanied by the release of chemotherapeutic drug purposed to photothermal synergizing. We synthesize iminosydnone‐lonidamine (ImLND) as a prodrug and choose dibenzocyclooctyne (DBCO) as the trigger of BCR reaction. A PEGylated AuNPs‐based two‐component nanoplatform consisting of prodrug‐loaded AuNPs‐ImLND and tumor‐targeting peptide RGD‐conjugated AuNPs‐DBCO‐RGD is designed. In the therapeutic regimen, AuNPs‐DBCO‐RGD are intravenously injected first for tumor‐specific enrichment and retention. Once the arrival of AuNPs‐ImLND injected later at tumor site, highly photothermally active nanoaggregates of AuNPs are formed via the BCR reaction between ImLND and DBCO. The simultaneous release of lonidamine further enhanced the therapeutic performance by sensitizing cancer cells to PTT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan, 430072, P. R. China.
ORCID-Profile: Chuan-Jun Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Yan, X., Li, K., Xie, T. Q., Jin, X. K., Zhang, C., Li, Q. R., Feng, J., Liu, C. J., & Zhang, X. Z. (2024). Bioorthogonal “Click and Release” Reaction‐Triggered Aggregation of Gold Nanoparticles Combined with Released Lonidamine for Enhanced Cancer Photothermal Therapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202318539
Vancouver
Yan X, Li K, Xie TQ, Jin XK, Zhang C, Li QR, et al. Bioorthogonal “Click and Release” Reaction‐Triggered Aggregation of Gold Nanoparticles Combined with Released Lonidamine for Enhanced Cancer Photothermal Therapy. Angewandte Chemie International Edition. 2024. doi:10.1002/anie.202318539
BibTeX
@article{Yan2024,
author = {Yan, Xiao and Li, Ke and Xie, Tian-Qiu and Jin, Xiao-Kang and Zhang, Cheng and Li, Qian-Ru and Feng, Jun and Liu, Chuan-Jun and Zhang, Xian-Zheng},
title = {Bioorthogonal “Click and Release” Reaction‐Triggered Aggregation of Gold Nanoparticles Combined with Released Lonidamine for Enhanced Cancer Photothermal Therapy},
journal = {Angewandte Chemie International Edition},
year = {2024},
doi = {10.1002/anie.202318539}
}
EUVIMED